Drug manufacturers are asking Michigan state legislators to erase language in a new state law that Michigan hospitals say bars the companies from withholding 340B pricing if a covered entity refuses to hand over its contract pharmacy claims data, 340B Report has learned.
Pharmaceutical Research and Manufacturers of America (PhRMA) yesterday declined to address its lobbying efforts. It said, though, that “claims modifiers and other claims-level data are critical to increasing transparency and ensuring the integrity of the 340B program.”
Drug manufacturers are asking Michigan state legislators to erase language in a new state law that Michigan hospitals say bars the companies from withholding 340B pricing if a covered entity refuses to hand over its contract pharmacy claims data, 340B Report has learned.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
